Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Investig Drugs. 2008 Apr;9(4):422-9.

Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.

Author information

1
West Virginia University School of Medicine, Robert C Byrd Health Sciences Center, Morgantown, WV 26506-9100, USA.

Abstract

Savient Pharmaceuticals Inc (formerly Bio-Technology General Corp), under license from Duke University, is developing pegloticase, PEG conjugates of uricase (urate oxidase), for the potential treatment of gout. The in-life portion of the phase III trials have been completed.

PMID:
18393109
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center